Boris Johnson plans trip to India to tout Britain’s vaccine success and deepen trade relations
Boris Johnson is planning a springtime trip to India to tout Britain’s vaccine success and push for progress on deepening trade relations after Brexit.
India asks states to prioritise vaccinations in areas with surging Covid-19 cases
NEw Delhi: India's federal government on Saturday asked local authorities to prioritise COVID-19 vaccinations in several districts of eight states including New Delhi that have seen a spike in coronavirus cases in recent weeks, it said in a statement.
Serum Institute CEO warns of shortage of vaccine components
And so, another working week will soon draw to a close.Not a moment too soon, yes?This is, you may recall, our treasured signal to daydream about weekend plans.
Coronavirus: Adar Poonawalla warns of raw material shortage for vaccine production due to US law
Serum Institute of India and World Health Organization chief scientist Soumya Swaminathan have warned of a shortage in raw materials needed to manufacture coronavirus vaccines, Bloomberg reported on Thursday.
Serum Institute writes to PMO seeking reforms in drug regulations on non-COVID vaccines
Manufacture and stockpile of Covishield doses during the clinical trial helped bring the vaccine out quicker, protecting millions of lives, the letter said.
Disclose your capacity to manufacture Covid vaccines, Delhi HC tells Serum Institute, Bharat Biotech
The Delhi High Court on Friday directed India’s coronavirus vaccine producers – Serum Institute of India and Bharat Biotech – to disclose their capacity to manufacture their Covaxin and Covishield vaccines, Live Law reported.
'We can do 50 lakh vaccinations per day'
'We have 25,000 private hospitals participating in this exercise and if each of these hospitals does 200 vaccinations per day, that makes it 50 lakhs.'
Efficacy data for India's own COVID-19 vaccine could boost public acceptance
By Krishna N. Das/ Reuters NEW DELHI: Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, making people reluctant to receive the shot.
Covaxin showed 81% efficacy in third phase trials, says Bharat Biotech
Pharmaceutical company Bharat Biotech on Wednesday said that its coronavirus vaccine Covaxin has shown 81% efficacy in the third phase of trials, NDTV reported.
UK to receive 10 million AstraZeneca COVID-19 vaccine doses from India's Serum Institute
(Reuters) - The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said in a statement on Tuesday.
Chinese hackers target Indian vaccine makers
Chinese hacking group APT10, also known as Stone Panda, identified gaps in the IT infra and supply chain software of Bharat Biotech and SII In the case of Serum Institute, hackers have found a number of their public servers running weak web servers, these are vulnerable web servers. — Representational
A billion-plus covid-19 shots in 2021. Can Serum Institute do it?
ON MARCH 5TH 2020 Mumbai’s horseracing season culminated with the Poonawalla Breeders’ Multimillion, a day-long extravaganza dominated by India’s first family of the sport, the Poonawallas.
Govt asks Serum Institute and Bharat Biotech to ramp up supply of Covishield and Covaxin
The government has asked vaccine makers Serum Institute of India and Bharat Biotech to ramp up supply of Covishield and Covaxin, respectively.Serum Institute has until now supplied about 4.6 crore doses of its vaccine and is scheduled to supply another 1 crore doses.
Nepal worried about future supply of COVID-19 vaccines
KATHMANDU, Nepal (AP) — Nepal has had a successful start of its COVID-19 vaccination campaign, but authorities are worried about future supplies as the country competes with dozens of other nations for much-sought vaccines produced by a handful of manufacturers.